Overview

Efficacy and Safety of Lu AA34893 in Patients With Major Depressive Disorder

Status:
Terminated
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy, safety and tolerability of three fixed dosages of Lu AA34893 compared to placebo in the treatment of patients with Major Depressive Disorder.
Phase:
Phase 2
Details
Lead Sponsor:
H. Lundbeck A/S
Treatments:
Venlafaxine Hydrochloride